论著-头颈部
食管癌SIB-IMRT与 3DCRT的剂量学疗效 比较*
作者:刘 杨 毛荣虎 贾丽洁 蒋 月 杨原源
所属单位:郑州大学附属肿瘤医院(河南省肿 瘤医院)放疗科 (河南 郑州 450008)
PDF摘要
目的 比较食管癌同期加量调强 放疗(SIB-IMRT)与三维适形放疗(3DCRT) 的剂量学疗效。 方 法 选择2010年1 月-2012年12月于我院接受3DCRT治疗的60 例食管癌患者作为3DCRT组,按1:1比例选 取2013年1月-2016年2月于我院接受SIBIMRT治疗的60例患者作为SIB-IMRT组,收 集所有患者的临床资料,比较两组靶区剂 量分布及靶区适形度指数(CI)、剂量均 匀指数(HI)及危及器官组织受量,比较 SIB-IMRT、3DCRT治疗的效果及安全性。 结果 ①SIB-IMRT组靶区Dmin、Dmean、 V95、D95%及靶区肿瘤体积(GTV)Dmin、 Dmean与计划靶体积(PTV)Dmax、Dmin、 Dmean均高于3DCRT组(P<0.05);②SIBIMRT组CI高于3DCRT组,其HI低于3DCRT 组(P<0.05);③SIB-IMRT组脊髓Dmax、 肺V30低于3DCRT组,其肺V5高于3DCRT组 (P<0.05);④SIB-IMRT组放射性食管炎发 生率低于3DCRT组(P<0.05)。结论 采用 SIB-IMRT放疗计划治疗食管癌靶区剂量分 布均匀性高,适形度好,危及器官受量 低,安全性高。
Objective To compare the dosimetry curative effect between simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) and threedimensional conformal radiation therapy (3DCRT) for esophageal carcinoma. Methods 60 cases of patients with esophageal carcinoma who were treated by 3DCRT in our hospital during January 2010 to December 2012 were included into 3DCRT group, and another 60 cases treated by SIB-IMRT during January 2013 to February 2016 were included into SIB-IMRT group. The clinical data of all patients were collected. The dose distribution and conformal index (CI) of target region, dose homogeneity index (HI) and the dose received by involved organs were compared between the two groups, and the efficacy and safety of SIB-IMRT and 3DCRT were compared. Results ①Dmin, Dmean, V95 and D95% of target region, Dmin and Dmean of the gross tumor volume (GTV), Dmax, Dmin and Dmean of planning target volume (PTV) in SIB-IMRT group were higher than those in 3DCRT group (P<0.05). ②CI in SIB-IMRT group was higher than that in 3DCRT group while HI was lower than that in 3DCRT group (P<0.05). ③The spinal cord Dmax and lung V30 in SIB-IMRT group were lower than those in 3DCRT group and the lung V5 was higher than that in 3DCRT group (P<0.05). ④The incidence of radiation esophagitis in SIB-IMRT group was lower than that in 3DCRT group (P<0.05). Conclusion The treatment of esophageal carcinoma with SIB-IMRT is with high homogeneity, good conformity, low dose received by involved organs and high safety.
【关键词】食管癌;调强放疗;三维适形 放疗;剂量学
【中图分类号】R735.1
【文献标识码】A
【DOI】 10.3969/j.issn.1672- 5131.2018.06.008
前言
食管癌是临床常见恶性肿瘤,放疗是目前治疗食管癌的常规手 段,但常规放疗受到技术的限制,放射剂量无法完全集中于靶区,且 靶区定位及精度差,导致相邻重要正常组织过量照射,增加放射毒性 反应[1]。三维适形放疗(3DCRT)则为传统放疗基础上发展的新方案,可 在三维影像方法指导下界定靶区照射剂量,增加肿瘤组织剂量,减少 人体正常组织受量,降低相关并发症发生风险,目前已被证实其在非 小细胞肺癌、前列腺癌中有其肯定的疗效,且明显优于常规化疗[2]。 但其对靶区形状复杂的瘤体或伴正常敏感组织包饶的肿瘤患者其应用 价值受限。相对而言,调强放疗(IMRT)属更为先进的放疗手段,其在 调节入射束流形状的同时可进行强度调节,与3DCRT比较,可将放射剂 量更好地集中于肿瘤靶区,同时保护周围正常组织及邻近器官,有助 于提供肿瘤控制率,减少并发症[3]。且同期加量调强放疗(SIB-IMRT) 其可实现肿瘤区加量与预防区低剂量分割,缩短总治疗时间,提高肿 瘤区生物剂量。但早期研究多围绕常规IMRT与3DCRT在肿瘤放疗中的应 用价值展开[4],而对SIB-IMRT在食管癌中的剂量学优势尚少见报道。 基于此,为探讨SIB-IMRT、3DCRT在食管癌临床治疗中的应用价值,现 对收治的120例患者的临床资料进行了回顾性分析,报道如下。
中国CT和MRI杂志
第16卷, 第 6 期
2018年06月
相关文章